[go: up one dir, main page]

BR9610234A - Uso de lipídeos - Google Patents

Uso de lipídeos

Info

Publication number
BR9610234A
BR9610234A BR9610234A BR9610234A BR9610234A BR 9610234 A BR9610234 A BR 9610234A BR 9610234 A BR9610234 A BR 9610234A BR 9610234 A BR9610234 A BR 9610234A BR 9610234 A BR9610234 A BR 9610234A
Authority
BR
Brazil
Prior art keywords
lipids
Prior art date
Application number
BR9610234A
Other languages
English (en)
Inventor
Joerg Rosenberg
Jorg Breitenbach
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of BR9610234A publication Critical patent/BR9610234A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
BR9610234A 1995-08-25 1996-08-21 Uso de lipídeos BR9610234A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19531277A DE19531277A1 (de) 1995-08-25 1995-08-25 Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren
PCT/EP1996/003667 WO1997007786A2 (de) 1995-08-25 1996-08-21 Verwendung von lipiden als hilfsmittel bei der herstellung von festen arzneiformen nach dem schmelzextrusionsverfahren

Publications (1)

Publication Number Publication Date
BR9610234A true BR9610234A (pt) 1999-06-29

Family

ID=7770352

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9610234A BR9610234A (pt) 1995-08-25 1996-08-21 Uso de lipídeos

Country Status (13)

Country Link
US (1) US6387401B2 (pt)
EP (1) EP0845982B1 (pt)
AR (1) AR003345A1 (pt)
AT (1) ATE210970T1 (pt)
AU (1) AU6875396A (pt)
BR (1) BR9610234A (pt)
CA (1) CA2227272C (pt)
DE (2) DE19531277A1 (pt)
DK (1) DK0845982T3 (pt)
ES (1) ES2170259T3 (pt)
HR (1) HRP960381A2 (pt)
WO (1) WO1997007786A2 (pt)
ZA (1) ZA967170B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1137402A1 (en) * 1998-12-08 2001-10-04 Phares Pharmaceutical Research N.V. Phospholipid compositions
DE19916383A1 (de) * 1999-03-31 2000-10-05 Schering Ag Pharmazeutische Zusammensetzung mit einem Extrusionsstoff
KR100710118B1 (ko) * 1999-07-30 2007-04-23 스미스클라인비이참피이엘시이 다성분 제약학적 제형
EP1175205B1 (en) 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
DE10026699A1 (de) * 2000-05-30 2001-12-06 Basf Ag Formulierung auf Heparin-, Glycosaminoglycan- oder Heparinoidbasis und Verwendung der Formulierung sowie der Formulierungsgrundlage
US7883721B2 (en) 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
US20050175687A1 (en) * 2001-01-30 2005-08-11 Mcallister Stephen M. Pharmaceutical formulations
GB0102342D0 (en) 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
TW200526274A (en) 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
BRPI0417348A (pt) * 2003-12-04 2007-03-13 Pfizer Prod Inc processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo
PE20060003A1 (es) * 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion
US20070237823A1 (en) * 2004-05-04 2007-10-11 Thomas Bock Solid Pharmaceutical Form Comprising and Ltb4 Antagonist
EP1693045A1 (de) 2005-02-17 2006-08-23 Abbott GmbH & Co. KG Herstellung von Dosierungsformen aus wirkstoffhaltigen Schmelzen
SI2200588T1 (sl) 2007-09-25 2019-08-30 Solubest Ltd. Sestavki, ki obsegajo lipofilne aktivne spojine, in postopek za njihovo pripravo
EP2219624A2 (en) 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations
US20100074947A1 (en) * 2008-06-13 2010-03-25 Adrian Brown Pharmaceutical Formulations
CN103124552A (zh) 2010-09-22 2013-05-29 麦克内尔-Ppc股份有限公司 由施以能量的粉末共混物制造片剂
AT511581A1 (de) * 2011-05-26 2012-12-15 G L Pharma Gmbh Orale retardierende formulierung
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
DE102017106216A1 (de) * 2017-03-22 2018-09-27 Amw Gmbh Extrudierte Depotform zur anhaltenden Wirkstofffreisetzung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
DE4226753A1 (de) 1992-08-13 1994-02-17 Basf Ag Wirkstoffe enthaltende Zubereitungen in Form fester Teilchen
MX9603480A (es) * 1994-02-16 1997-12-31 Abbott Lab Procedimiento para preparar formulaciones farmaceuticas en particulas finas.
DE4413350A1 (de) 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19504832A1 (de) 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen

Also Published As

Publication number Publication date
US6387401B2 (en) 2002-05-14
AU6875396A (en) 1997-03-19
CA2227272C (en) 2007-12-11
AR003345A1 (es) 1998-07-08
ATE210970T1 (de) 2002-01-15
ZA967170B (en) 1998-03-02
WO1997007786A3 (de) 1997-04-03
CA2227272A1 (en) 1997-03-06
US20010007664A1 (en) 2001-07-12
DE59608516D1 (de) 2002-01-31
ES2170259T3 (es) 2002-08-01
HRP960381A2 (en) 1998-02-28
DK0845982T3 (da) 2002-03-25
WO1997007786A2 (de) 1997-03-06
EP0845982A2 (de) 1998-06-10
EP0845982B1 (de) 2001-12-19
DE19531277A1 (de) 1997-02-27

Similar Documents

Publication Publication Date Title
BR9610234A (pt) Uso de lipídeos
LV11983A (lv) Iekskigi lietojams 2-metil-tieno-benzodiazepina zalu preparats
DE69627435D1 (de) Axiallüfter
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
DE69609615D1 (de) Windel
DE69625291D1 (de) Axiallüfter
DK0825860T3 (da) Præpart
ATA181095A (de) Probiotisch wirksame formulierung
FI964193A7 (fi) Puriinien valmistaminen
EP0759372A3 (de) Kombinationsinstrument
FI952176A7 (fi) Suovan neutralointi
MA23794A1 (fr) Utilisation de phenylcyclohexylcarboxamides
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
FI953319A0 (fi) Dimetyylinaftaleenin valmistus
FI98053B (fi) Sekoitus
KR970041939U (ko) 부품의 방진체결구조
BR9504322A (pt) Aerodisco - veículo aeronáutico atmosférico
FR2763940B1 (fr) Preparation de trifluoromethoxy-2-aniline
UA1112S (uk) Мікро-еом широкого призначення
PT761766E (pt) Compostos assimetricos de trifenilenodioxazina
KR960030383U (ko) 등미는 손
SE9502290D0 (sv) New Preparation
SE9500036D0 (sv) Formulation
KR960034358U (ko) 잭-판토그래프의 고정 구조
SE9501159D0 (sv) Hydrering av lipider

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law